Evidence map›Paper›PMID 28428273›Full record

ArticleCancer research2017

Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion.

Hsin-Yu Chen, Peder E Z Larson, Robert A Bok, Cornelius von Morze, Renuka Sriram, Romelyn Delos Santos, Justin Delos Santos, Jeremy W Gordon, Naeim Bahrami, Marcus Ferrone and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. In vivo Human MR Spectroscopy Using a Clinical Scanner: Development, Applications, and Future Prospects.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2022
    Review
  13. Clinical translation of hyperpolarizedMagnetic resonance in medicine · 2022
    Article
  14. Review
  15. Article
  16. HyperpolarizedNMR in biomedicine · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hsin-Yu ChenGraduate Program in Bioengineering, University of California, San Francisco, San Francisco, California.
Peder E Z LarsonGraduate Program in Bioengineering, University of California, San Francisco, San Francisco, California.
Robert A BokDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Cornelius von MorzeDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Renuka SriramDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Romelyn Delos SantosDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Justin Delos SantosDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Jeremy W GordonDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Naeim BahramiDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Marcus FerroneDepartment of Clinical Pharmacy, University of California, San Francisco, San Francisco, California.
John KurhanewiczGraduate Program in Bioengineering, University of California, San Francisco, San Francisco, California.
Daniel B VigneronGraduate Program in Bioengineering, University of California, San Francisco, San Francisco, California. Dan.Vigneron@ucsf.edu.
University of California, San Francisco · US

Funding

TR&D3: Open-Source Tools for Processing Hyperpolarized MR DataP41EB013598 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUAN XU · 2011 to 2026
$19.9M
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI MethodsR01EB017449 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KURHANEWICZ, JOHN, VIGNERON, DANIEL B · 2013 to 2017
$5.9M
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer TherapyR01CA166655 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KURHANEWICZ, JOHN, VIGNERON, DANIEL B · 2012 to 2016
$3.0M
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRIR01EB013427 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KURHANEWICZ, JOHN, VIGNERON, DANIEL B · 2013 to 2016
$2.8M
NCI NIH HHS R01 CA166655NIBIB NIH HHS P41 EB013598NIBIB NIH HHS R01 EB013427NIBIB NIH HHS R01 EB017449
6 · The paper itself

Abstract

New magnetic resonance (MR) molecular imaging techniques offer the potential for noninvasive, simultaneous quantification of metabolic and perfusion parameters in tumors. This study applied a three-dimensional dynamic dual-agent hyperpolarized

Indexed as

AdenocarcinomaAnimalsCarbon IsotopesImaging, Three-DimensionalMagnetic Resonance ImagingMaleMiceMice, Inbred C57BLMice, TransgenicProstatic NeoplasmsRadionuclide ImagingRadiopharmaceuticalsCarbon IsotopesRadiopharmaceuticals

Identifiers

PMID28428273
PMCPMC5484421
OpenAlexW2605487105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.